𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era

✍ Scribed by Ritsuko Seki; Koichi Ohshima; Tomoaki Fujisaki; Naokuni Uike; Fumio Kawano; Hisashi Gondo; Shigeyoshi Makino; Tetsuya Eto; Yukiyoshi Moriuchi; Fumihiro Taguchi; Tomohiko Kamimura; Hiroyuki Tsuda; Ryosuke Ogawa; Kazuya Shimoda; Kiyoshi Yamashita; Keiko Suzuki; Hitoshi Suzushima; Kunihiro Tsukazaki; Masakazu Higuchi; Atae Utsunomiya; Masahiro Iwahashi; Yutaka Imamura; Kazuo Tamura; Junji Suzumiya; Minoru Yoshida; Yasunobu Abe; Tadashi Matsumoto; Takashi Okamura

Book ID
108586463
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
458 KB
Volume
100
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Biomarkers of potential prognostic signi
Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma
✍ Grace Wu; Armand Keating πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 116 KB

## Abstract Diffuse large B‐cell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A